BACKGROUND: The aims of this study were to analyse the serum concentrations of clusterin (CLU) in patients with hand osteoarthritis (OA) and in healthy controls, to compare CLU levels between patients with erosive and non-erosive disease, and to examine the association of CLU levels with clinical and laboratory parameters. METHODS: A total of 135 patients with hand OA (81 with erosive and 54 with non-erosive disease) and 53 healthy individuals were included in this study. All patients underwent clinical and hand joint ultrasound examination. The Australian/Canadian (AUSCAN) hand osteoarthritis index, algofunctional index and a visual analogue scale (VAS) for the measurement of pain were assessed. Serum levels of CLU were measured by an enzyme-linked immunosorbent assay (ELISA). RESULTS: Serum levels of CLU were significantly lower in patients with hand OA than in control subjects (p < 0.0001). In addition, patients with erosive hand OA had significantly lower CLU levels than those with non-erosive disease (p = 0.044). Negative correlations between CLU levels and pain as assessed by the AUSCAN score and the VAS were found in patients with erosive hand OA (r = - 0.275; p = 0.013 and r = - 0.220; p = 0.049, respectively). CONCLUSION: The present study demonstrates that lower concentrations of CLU are found in hand OA patients than in healthy individuals, especially in those with erosive disease, and that CLU concentrations have a negative association with hand pain.

Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Rheumatology Prague Czech Republic

Zobrazit více v PubMed

Dahaghin S, Bierma-Zeinstra SMA, Ginai AZ, Pols HAP, Hazes JMW, Koes BW. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study) Ann Rheum Dis. 2005;64:682–687. doi: 10.1136/ard.2004.023564. PubMed DOI PMC

Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham study. Am J Epidemiol. 2002;156:1021–1027. doi: 10.1093/aje/kwf141. PubMed DOI

Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009;68:8–17. doi: 10.1136/ard.2007.084772. PubMed DOI

Poon S, Easterbrook-Smith SB, Rybchyn MS, Carver JA, Wilson MR. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry. 2000;39:15953–15960. doi: 10.1021/bi002189x. PubMed DOI

Trougakos IP, Lourda M, Antonelou MH, Kletsas D, Gorgoulis VG, Papassideri IS, et al. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res. 2009;15:48–59. doi: 10.1158/1078-0432.CCR-08-1805. PubMed DOI PMC

Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem. 2003;278:11590–11600. doi: 10.1074/jbc.M209233200. PubMed DOI

Kim N, Yoo JC, Han JY, Hwang EM, Kim YS, Jeong EY, et al. Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain. J Cell Physiol. 2012;227:1157–1167. doi: 10.1002/jcp.22836. PubMed DOI

Prochnow H, Gollan R, Rohne P, Hassemer M, Koch-Brandt C, Baiersdörfer M. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway. PLoS One. 2013;8:e75303. doi: 10.1371/journal.pone.0075303. PubMed DOI PMC

Connor JR, Kumar S, Sathe G, Mooney J, O’Brien SP, Mui P, et al. Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthr Cartil. 2001;9:727–737. doi: 10.1053/joca.2001.0475. PubMed DOI

Fandridis E, Apergis G, Korres DS, Nikolopoulos K, Zoubos AB, Papassideri I, et al. Increased expression levels of apolipoprotein J/clusterin during primary osteoarthritis. In Vivo (Brooklyn) 2011;25:745–749. PubMed

Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S, et al. Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J Immunol. 2006;177:6471–6479. doi: 10.4049/jimmunol.177.9.6471. PubMed DOI

Falgarone G, Essabbani A, Dumont F, Cagnard N, Mistou S, Chiocchia G. Implication of clusterin in TNF-α response of rheumatoid synovitis: lesson from in vitro knock-down of clusterin in human synovial fibroblast cells. Physiol Genomics. 2012;44:229–235. doi: 10.1152/physiolgenomics.00095.2010. PubMed DOI

Choi B, Kang S-S, Kang S-W, Min B-H, Lee E-J, Song D-H, et al. Secretory clusterin inhibits osteoclastogenesis by attenuating M-CSF-dependent osteoclast precursor cell proliferation. Biochem Biophys Res Commun. 2014;450:105–109. doi: 10.1016/j.bbrc.2014.05.074. PubMed DOI

Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33:1601–1610. doi: 10.1002/art.1780331101. PubMed DOI

Hurnakova J, Zavada J, Hanova P, Hulejova H, Klein M, Mann H, et al. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Res Ther. 2015;17:252. doi: 10.1186/s13075-015-0764-5. PubMed DOI PMC

Bellamy N, Campbell J, Haraoui B, Gerecz-Simon E, Buchbinder R, Hobby K, et al. Clinimetric properties of the AUSCAN osteoarthritis hand index: an evaluation of reliability, validity and responsiveness. Osteoarthr Cartil. 2002;10:863–869. doi: 10.1053/joca.2002.0838. PubMed DOI

Dreiser RL, Maheu E, Guillou GB, Caspard H, Grouin JM. Validation of an algofunctional index for osteoarthritis of the hand. Rev Rhum Engl Ed. 1995;62:43S–53S. PubMed

Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502. doi: 10.1136/ard.16.4.494. PubMed DOI PMC

Addimanda O, Mancarella L, Dolzani P, Punzi L, Fioravanti A, Pignotti E, et al. Clinical and radiographic distribution of structural damage in erosive and nonerosive hand osteoarthritis. Arthritis Care Res. 2012;64:1046–1053. doi: 10.1002/art.33454. PubMed DOI

Bijsterbosch J, Watt I, Meulenbelt I, Rosendaal FR, Huizinga TWJ, Kloppenburg M. Clinical burden of erosive hand osteoarthritis and its relationship to nodes. Ann Rheum Dis. 2010;69:1784–1788. doi: 10.1136/ard.2009.125435. PubMed DOI

Kortekaas MC, Kwok W-Y, Reijnierse M, Huizinga TWJ, Kloppenburg M. In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann Rheum Dis. 2013;72:930–934. doi: 10.1136/annrheumdis-2012-201458. PubMed DOI

Haugen IK, Mathiessen A, Slatkowsky-Christensen B, Magnusson K, Bøyesen P, Sesseng S, et al. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype? Osteoarthr Cartil. 2016;24:647–654. doi: 10.1016/j.joca.2015.11.014. PubMed DOI

Punzi L, Ramonda R, Oliviero F, Sfriso P, Mussap M, Plebani M, et al. Value of C reactive protein in the assessment of erosive osteoarthritis of the hand. Ann Rheum Dis. 2005;64:955–957. doi: 10.1136/ard.2004.029892. PubMed DOI PMC

Filková M, Senolt L, Braun M, Hulejová H, Pavelková A, Sléglová O, et al. Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthr Cartil. 2009;17:1615–1619. doi: 10.1016/j.joca.2009.06.002. PubMed DOI

Dolzani P, Assirelli E, Pulsatelli L, Addimanda O, Mancarella L, Peri G, et al. Systemic inflammation and antibodies to citrullinated peptides in hand osteoarthritis. Clin Exp Rheumatol. 29:1006–9. PubMed

Lennerová T, Pavelka K, Šenolt L. Biomarkers of hand osteoarthritis. Rheumatol Int. 2018;38:725–735. doi: 10.1007/s00296-017-3864-5. PubMed DOI

Fioravanti A, Tenti S, Pulsatelli L, Addimanda O. Could myeloperoxidase represent a useful biomarker for erosive osteoarthritis of the hand? Scand J Rheumatol. 2018;1-3. doi: 10.1080/03009742.2017.1386796. [Epub ahead of print] PubMed

Punzi L, Ramonda R, Deberg M, Frallonardo P, Campana C, Musacchio E, et al. Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthr Cartil. 2012;20:557–561. doi: 10.1016/j.joca.2012.02.638. PubMed DOI

Cunin P, Beauvillain C, Miot C, Augusto J-F, Preisser L, Blanchard S, et al. Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. Cell Death Dis. 2016;7:e2215. doi: 10.1038/cddis.2016.113. PubMed DOI PMC

Newkirk MM, Apostolakos P, Neville C, Fortin PR. Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory protein. J Rheumatol. 1999;26:597–603. PubMed

Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response

Chemokine and Cytokine Profiles in Patients with Hand Osteoarthritis